Heat acclimation protocol
Decision matrix
Key Findings (the decision this matrix makes)
The apparent contradiction
Resolution
The literature is context-dependent, not contradictory. Select the protocol by three criteria:
1. What are you trying to adapt?
| Adaptation target | Protocol with data in this base (inference across separate studies; no head-to-head comparison) |
|---|---|
| Plasma volume expansion (+6.5% REF-001; pooled +5.6% REF-3491) | Active exercise in heat 40°C (REF-001); post-exercise sauna is the base's own practice, not measured for plasma volume in REF-334b |
| Haemoglobin mass (+33 g, REF-135) | Passive hot water immersion ≥40°C 45 min 5×/week × 5 weeks (REF-135); each extra exposure in the pooled literature adds ~+1.9 g (REF-3491) |
| Thermoregulatory (sweat, core temp) | Active exercise in heat (pooled: sweat rate +163 mL/h, end-exercise core temp −0.43 °C, REF-3491) |
| Performance in cool conditions | Active exercise-in-heat (+6% TT and +5% VO2max in cool, REF-001); passive immersion also raised VO2max +2.7 mL/kg/min (REF-135) |
2. What practical constraints apply?
Not from a study; the base's own practice, with the source of each number given:
| Constraint | Recommended |
|---|---|
| No chamber access | Overdressing outdoor training (target core ≥38.5°C; 30-60 min Z1-Z2 — the 38.5 °C/60 min target is the controlled-hyperthermia dose of REF-3489) |
| Time-limited, post-training window | 15-30 min sauna immediately after training (base practice; REF-334b pooled post-exercise sauna and HWI but its abstract gives no temperatures or durations) |
| Injured / unable to train in heat | Passive hot water immersion ≥40°C, 45 min (REF-135) |
| Home-based amateur | HWI has a controlled crossover behind it (REF-135, n=10 well-trained runners); sauna rests only on the low-certainty passive pool (REF-334b); chamber not required |
3. What is the athlete's current adaptation state?
Caveats based on [REF-334b] meta-analysis
The dose, as a dose-response rather than a judgement ([REF-3491])
Bayesian meta-regression over 211 papers (participant count, 8.9% female and mean VO2max 52.6 ± 7.7 mL/kg/min are full text, checked 2026-09-27). Posterior means with 90% credible intervals.
| Question | What the pooled data say |
|---|---|
| What did the literature actually run? | 8 ± 4 exposures, 90 ± 36 min each, 39.1 ± 4.8 °C, 2.78 ± 0.83 kPa |
| What does the whole block buy? | Time trial +3.1% [1.8, 4.5]; end-exercise HR −17 bpm [−19, −14]; end-exercise core temp −0.43 °C [−0.48, −0.36]; plasma volume +5.6% [3.8, 7.0]; sweat rate +163 mL/h [94, 226] |
| What does ONE MORE SESSION buy? | Haemoglobin mass +1.9 g [0.6, 3.2] and sweat rate +9 mL/h [1, 17] — and (full text, checked 2026-09-27) essentially nothing more for end-exercise heart rate (0.0 bpm [−0.4, 0.4]) or plasma volume (−0.1% [−0.2, 0.1]) |
| What do 15 MORE MINUTES per session buy? | Core temp −0.04 °C [−0.05, −0.03], plasma volume +0.4% [0.1, 0.7] (end-exercise HR −1.1 bpm [−1.6, −0.5] is full text, checked 2026-09-27) |
| Does the method matter? | Barely, for the two main markers: end-exercise core temperature fell −0.43 °C under controlled hyperthermia and −0.45 °C at constant work rate |
| Hotter or more humid? | +5 °C → −2 bpm [−3, −1] end-exercise HR; +1 kPa → +37 mL/h [4, 72] sweat rate |
Practical Application
Limitations
How this entry was checked and changed
(the dose table is B+; the protocol matrix is an inference across separate small trials with no head-to-head comparison, and the access, maintenance and monitoring rows are practice — synthesis over two A- meta-analyses — REF-3491, and REF-334b whose pooled evidence is graded low-to-very-low certainty — plus B+ trials REF-001, REF-3489 and a B crossover REF-135)